Federal Judge Orders Permanent Injunction to Stop Company from Selling Hemp Seed Oil
- A Bronx company that sells hemp products is receiving an injunction from a federal judge.
- The injunction follows a complaint that was filed against the company on behalf of the FDA.
- Sundial Herbal Products must now receive written permission from the FDA in order to continue operations.
A New York company is being forced to stop distributing hemp seed oil after a federal judge orders a permanent injunction. The given order was a result of a complaint filed by the U.S. Department of Justice on behalf of the U.S. Food and Drug Administration (FDA).
The complaint was originally filed against Sundial Herbal Products after several inspections that took place over 5 years, ranging from 2012 to 2017. The company also received a warning letter from the FDA in 2013.
Sundial Herbal Products, located in the Bronx, New York, is ran by Rahsan Hakim and Adoniiah Rahsa. They continuously responded to the warning letter that was issued to them and made promises to correct the violation; however, they are continuing to sell products in the same manner and make outlandish claims that are not back by research in the slightest.
Sundial claimed that its organic hemp seed oil could suppress the growth of cancer while also claiming that their other products could cure, treat, or prevent cancer, AIDS, and other diseases.
“Americans expect and deserve medical treatments that have been scientifically proven to be safe and effective. Making claims that unproven drugs can cure or prevent diseases places consumers’ health at risk,” stated FDA Chief Counsel Stacy Amin.
“We remain committed to pursuing and taking swift action against those who attempt to subvert the regulatory functions of the FDA by repeatedly disregarding the law and distributing unapproved products.”
Sundial Herbal’s injunction now prohibits the two people running the company from directly or indirectly receiving, labeling, holding, or distributing products from their facility until their products comply with the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Other required actions in the injunction include:
- Hire experts to guarantee conformity with the FD&C Act.
- Recall all drugs.
- Receive permission, via writing, from the FDA that grants them permission to resume operations.
This federal injunction is the first ever that is against a company selling hemp products.